scorecardresearch
Wednesday, July 23, 2025
TopicDengue

Topic: Dengue

How Serum Institute, DNDi tie-up for affordable antibody will bolster global fight against dengue

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'. 

MCD launches one-time property tax amnesty scheme, ramps up dengue prevention ahead of monsoon

Delhi Mayor Raja Iqbal Singh also announced removal of 'user charges' linked to garbage collection from the property tax, a measure opposed by both AAP, BJP and resident groups.

Dengue fever outbreak grips the world. 5 ways to stop it

Over four billion people are currently at risk from mosquito-borne infections, including dengue, Zika, and chikungunya. It's estimated to rise to five billion by 2050.

India may soon get 1st dengue vaccine, but wait for jab effective against all 4 strains could be longer

With govt's local clinical trials waiver for certain drugs and vaccines, Japanese firm Takeda may soon launch QDenga, which will be a boost for India’s fight against dengue.

India sees alarming rise in dengue cases even before peak season, steady increase over past 4 years

Most number of cases in southern states, Maharashtra. Experts stress need for policy & community action, say global warming may have contributed to proliferation of source mosquitoes.

Covid antibodies making dengue more severe, suggests study by govt-run institute

This preprint study is 1st to demonstrate anti-SARS-CoV-2 antibodies can cross-react with dengue virus serotype and enhance its infection through antibody-dependent enhancement.

Japan firm Takeda’s dengue vaccine gets WHO panel backing, but no nod yet for phase 3 trials in India

Takeda's QDENGA, designed to protect against all 4 dengue virus serotypes, has been recommended by Strategic Advisory Group of Experts on Immunization for use in endemic countries.

Top Reasons Why Dengue Cases Are Getting More Severe

Dengue fever, caused by the Aedes mosquito, has long been a concern in tropical and subtropical regions, including parts of Asia, Latin America, and the Caribbean.

Vaccine manufacturer Indian Immunologicals Ltd to launch dengue vaccine by January 2026

According to NCDC, there was a 333% surge in dengue cases from 2020 to 2021 and a 21% rise in number of cases between 2021 and 2022.

US FDA takes new dengue vaccine by Japanese firm Takeda for priority review

Takeda has carried out phase 3 trials of the vaccine candidate and found it to be 80.2% effective in preventing symptomatic dengue cases after a year of vaccination.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.